Christopher Benevides

Waters (United States)

Papers

1

Total Citations

43

H-Index

1

About

Christopher Benevides is a pioneering figure in high-throughput bioanalysis, whose work has fundamentally advanced the efficiency of liquid chromatography/tandem mass spectrometry (LC/MS/MS) in pharmaceutical research. His key contributions center on the development and validation of 384-well format solid phase extraction (SPE), a technique that dramatically accelerates sample preparation for clinical and preclinical studies. In his landmark 2000 paper, which has garnered 43 citations, Benevides demonstrated the practical application of this method by successfully extracting the 5-HT agonist sumatriptan from human plasma, effectively creating a "clinical trial on a plate." This innovation enabled researchers to process hundreds of samples simultaneously, reducing time and solvent use while maintaining analytical precision. His work has been instrumental in bridging the gap between high-throughput screening and rigorous bioanalytical validation, making him a respected authority in the field. Benevides’ achievements continue to influence modern drug development, where rapid, reliable bioanalysis is critical for moving candidates from bench to bedside.

Research Focus

Key Achievements

1
H-Index
1
Papers
43
Total Citations
43
Avg Citations/Paper
🏆 Most Cited Paper
A clinical trial on a plate? The potential of 384-well format solid phase extraction for high-throughput bioanalysis using liquid chromatography/tandem mass spectrometry
43 citations · 2000
📈 Most Prolific Year: 2000 (1 Papers)
🤝 Key Collaborators: 2
🏛 Institutions: Waters (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago